Lezack Adam
SEC Form 4 insider trading activity
Lezack Adam has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 26, 2026.
On the most recent filing, Lezack Adam is listed as Director at Beta Bionics, Inc. Inside the rolling window, Lezack Adam reported no open-market purchases and 4 open-market sales totaling $100K in BBNX. The largest disclosed transaction in the window is a sale of 1,406 BBNX shares on Dec 1, 2025, worth $42K.
Companies traded
Other insiders at BBNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$100K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lezack Adam made?
Lezack Adam has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Lezack Adam trade?
Lezack Adam has filed SEC Form 4 disclosures for 1 company, including BBNX.
When was Lezack Adam's most recent SEC Form 4 filing?
Lezack Adam's most recent SEC Form 4 filing on Tracefour is dated May 26, 2026.
What is Lezack Adam's total buy and sell value in the current window?
Inside the rolling retention window, Lezack Adam bought $0 and sold $100K based on SEC Form 4 filings.
What was Lezack Adam's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,406 BBNX shares on 2025-12-01, worth $42K, per SEC Form 4 filings.